prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Her2, Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: .1 nnDATE of LMP. DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: L BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: L NOD RAD WAT. CLINICAL HISTORY: MATERIAL SUEMITTED RIGHT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: CONSULT: Left breast tissue: Breast tissue with nipple/areola complex: Multilobed, diffuse breast mass. with. multifocal, individual firm secondary masses, malignant. Total dimension to be determined with gross. ADDENDA: Addendum. FINAL DIAGNOSIS: ER/PR. IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE. "A2". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGKN RECEPTOR (90%) AND PROGESTERONE RECEPTOR. (40%) THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. HER-2/NEU. c-erbB2 (HER-2/NEU) IMMUSTAINING IS CARRIED OUT ON SURGICAL. BLOCK "A2" (BREAST CANCER) USING A. 1:300 DILUTION OF DARO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN or c-erb82). WITHOUT ANTIGEN RETRIEVAL. DISTINCT COMPLETE MEMGRANE STAINING IS IDENTIFIED IN 30% or TUMOR CELLS. THEREFORE, c-erb82 (BER-2/NEU) IS INTERPRETED AS POSITIVE (SCORE 2+). My. signature is attestation that I have personally reviowed the submitted material(s) and the final. diagnosis reflects that evaluation. LEFT BREAST, MODIFIED RADICAL MASTECTOMY: INFILTRATING DAND INTRADUCTAL CARCINOMA OF THE BREAST, POOR NUCLEAR GRADE, 9 CM. - INTRADUCTAL CARCINOMA IS COMEDO-TYPE AND COMPRISES APPROXIMATELY 35% OF TUMOR VOLUME. - IN-SITU COMPONENT EXTENDS TO INVOLVE LARGE NIPPLE DUCTS. - NIPPLE SHOWING PAGST'S DISEASE. - TUMOR VASCULAR SPACE INVOLVING IS NOT PROMINENT. - SURGICAL MARGINS TREE OF TUMOR IN PLANES OF SECTION. - TUMOR INVOLVES ALL FOUR QUADRANTS, HOWEVER, RANDOM SECTIONS or QUADRANTS ARE NEGATIVE FOR TUMOR. - METASTATIC CARCINOMA INVOLVING THREE OF TEN (3/10) AXILLARY LYMPH NODES. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block "A2".

expanded version (tokens=1066) : 
 Histological Classification: Infiltrating ductal carcinoma of the breast, with a co-existing in-situ ductal carcinoma, poor nuclear grade, and HER2 subtype.

Subtype: HER2.

Description of Necrosis: No specific mention of necrosis in the report.

Tumor Infiltrating Lymphocytes: No mention of the presence or absence of tumor infiltrating lymphocytes.

Histological Grade: Poor nuclear grade.

Nuclear Grade: Poor nuclear grade.

Lymphovascular Invasion: The report mentions that "tumor vascular space involving is not prominent."

Calcification: No specific mention of calcification in the report.

Receptor Status: The ER and PR immunoperoxidase assay were carried out, and they were positive for both receptors (ER- 90%, PR - 40%).

IHC and Ancillary Testing Results: HER-2/NEU immunostaining was carried out on surgical block "A2" using a 1:300 dilution of Daro's polyclonal antibody A485, and distinct complete membrane staining was identified in 30% of tumor cells. Therefore, c-erb82 (HER-2/NEU) was interpreted as positive (score 2+).

Other Points: The report mentions Paget's disease involving the nipple, as well as negative margins in the planes of section after a modified radical mastectomy. Additionally, metastatic carcinoma was detected in three of ten axillary lymph nodes.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1201) : 
 Infiltrating ductal carcinoma of the breast, with in-situ ductal carcinoma and HER2 subtype found. Poor nuclear grade seen. ER and PR immunoperoxidase assay showed positivity for both receptors. HER-2/NEU testing scored 2+, with 30% complete membrane staining. Margins were negative, Paget's disease involved the nipple, and metastatic carcinoma found in some axillary lymph nodes.

